169 related articles for article (PubMed ID: 29348028)
1. Antithrombotic Therapy in Peripheral Artery Disease: Generating and Translating Evidence Into Practice.
Jones WS; Patel MR
J Am Coll Cardiol; 2018 Jan; 71(3):352-362. PubMed ID: 29348028
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic Therapy for Peripheral Artery Disease: Recent Advances.
Hussain MA; Al-Omran M; Creager MA; Anand SS; Verma S; Bhatt DL
J Am Coll Cardiol; 2018 May; 71(21):2450-2467. PubMed ID: 29793635
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic strategies for patients with coronary and lower extremity peripheral artery diseases: a narrative review.
De Luca L; Bonaca MP; Magnani G
Expert Rev Cardiovasc Ther; 2020 Dec; 18(12):881-889. PubMed ID: 33021875
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotics in stable peripheral artery disease.
Kaplovitch E; Rannelli L; Anand SS
Vasc Med; 2019 Apr; 24(2):132-140. PubMed ID: 30799766
[TBL] [Abstract][Full Text] [Related]
5. Tackling Elevated Risk in PAD: Focus on Antithrombotic and Lipid Therapy for PAD.
Govsyeyev N; Nehler MR; Hiatt WR; Bonaca MP
Curr Cardiol Rep; 2020 Jan; 22(3):13. PubMed ID: 31997026
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic treatment in peripheral artery disease.
Olinic DM; Tataru DA; Homorodean C; Spinu M; Olinic M
Vasa; 2018 Feb; 47(2):99-108. PubMed ID: 29160765
[TBL] [Abstract][Full Text] [Related]
7. Antithrombotic therapy in peripheral artery disease.
Foley TR; Waldo SW; Armstrong EJ
Vasc Med; 2016 Apr; 21(2):156-69. PubMed ID: 26823456
[TBL] [Abstract][Full Text] [Related]
8. A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative.
Hess CN; Norgren L; Ansel GM; Capell WH; Fletcher JP; Fowkes FGR; Gottsäter A; Hitos K; Jaff MR; Nordanstig J; Hiatt WR
Circulation; 2017 Jun; 135(25):2534-2555. PubMed ID: 28630267
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic therapy in peripheral artery disease: A review of the EUCLID trial results and current ongoing trials.
Ward R; Long C; Patel MR; Jones WS
Clin Cardiol; 2018 Jan; 41(1):137-143. PubMed ID: 29355992
[TBL] [Abstract][Full Text] [Related]
10. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
Berger JS; Abramson BL; Lopes RD; Heizer G; Rockhold FW; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Millegård M; Blomster J; Reist C; Hiatt WR; Patel MR; Mahaffey KW
Vasc Med; 2018 Dec; 23(6):523-530. PubMed ID: 29992857
[TBL] [Abstract][Full Text] [Related]
11. A Practical Guide to Understanding and Treating Peripheral Artery Disease.
Chilbert MR; Woodruff AE; Rogers KC
J Cardiovasc Pharmacol; 2024 Jun; 83(6):565-579. PubMed ID: 38452186
[TBL] [Abstract][Full Text] [Related]
12. Medical Therapy for Peripheral Artery Disease.
Canonico ME; Hess CN; Rogers RK; Bonaca MP
Curr Cardiol Rep; 2024 Jun; 26(6):651-659. PubMed ID: 38696099
[TBL] [Abstract][Full Text] [Related]
13. Current Evidence and Future Perspectives on Anti-platelet and Statin Pharmacotherapy for Patients with Symptomatic Peripheral Arterial Disease.
Kitrou P; Katsanos K; Karnabatidis D; Reppas L; Brountzos E; Spiliopoulos S
Curr Vasc Pharmacol; 2017; 15(5):430-445. PubMed ID: 28595535
[TBL] [Abstract][Full Text] [Related]
14. Is aspirin still the drug of choice for management of patients with peripheral arterial disease?
Poredos P; Jezovnik MK
Vasa; 2013 Mar; 42(2):88-95. PubMed ID: 23485835
[TBL] [Abstract][Full Text] [Related]
15. Systematic Literature Review of Randomized Trials Comparing Antithrombotic Therapy Following Revascularization Procedures in Patients With Peripheral Artery Disease.
Schindewolf M; Beyer-Westendorf J; Balradj J; Bowrin K; Huelsebeck M; Briere JB
Angiology; 2020 Oct; 71(9):773-790. PubMed ID: 32638610
[TBL] [Abstract][Full Text] [Related]
16. Adverse cardiovascular outcomes in relation to suboptimal antithrombotic therapy use in patients undergoing peripheral artery disease angioplasty: lost opportunities?
Bodansky DM; Allon IR; Apostolakis S; Lip GY
Int J Clin Pract; 2015 Feb; 69(2):162-8. PubMed ID: 24898695
[TBL] [Abstract][Full Text] [Related]
17. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J
J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from a Swedish nationwide study.
Sigvant B; Hasvold P; Kragsterman B; Falkenberg M; Johansson S; Thuresson M; Nordanstig J
J Vasc Surg; 2017 Aug; 66(2):507-514.e1. PubMed ID: 28433332
[TBL] [Abstract][Full Text] [Related]
19. Asymptomatic peripheral artery disease and antiplatelet management.
Raparelli V; Proietti M; Napoleone L; Bucci T; Talerico G; Pignataro FS; Basili S
Vasa; 2014 Sep; 43(5):309-25. PubMed ID: 25147008
[TBL] [Abstract][Full Text] [Related]
20. Screening for Peripheral Artery Disease Using the Ankle-Brachial Index: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Guirguis-Blake JM; Evans CV; Redmond N; Lin JS
JAMA; 2018 Jul; 320(2):184-196. PubMed ID: 29998343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
